On Tuesday, March 6th, Dr. David L. Wyles of Denver Health presented on: “Treatment for Hepatitis C: New Tests, New Drugs & New Recommendations”
1. Explain the epidemiology of the hepatitis C virus (HCV).
2. Discuss laboratory testing and diagnosis of HCV infection.
3. Design a therapeutic regimen and monitoring plan for the treatment of HCV.
Dr. David Wyles earned his medical degree from Northwestern University and complete internal medicine residency and infectious disease fellowship at the University of Colorado. Dr Wyles is an Associate Professor of Medicine in the Division of Infectious Diseases at the University of Colorado and Chief of the Division of Infectious Diseases at Denver Health Medical Center. Dr. Wyles’ research interests include HCV drug resistance and retreatment strategies and the treatment of HCV in vulnerable populations. He was an inaugural member of the AASLD/IDSA HCV guidelines panel. He currently serves on the International Antiviral Society – USA Hepatitis Advisory Board and the ACTG Hepatitis transformative science group. Clinically Dr. Wyles is involved in care of patients with HCV and HCV/HIV-1 co-infection.